Agenda

Agenda

All times are in Japan Local Time.
Program is subject to change.

Program details updated September 28, 2026.

Short Course Day 1 (Sat Nov 21, 2026)

Time Session Location People
8:30-9:00 AM Registration / Breakfast TBD
9:00 AM-12:30 PM Short Course 2: Decentralized Clinical Trials: Design, Conduct, and Analysis in the Digital Era TBD
Instructors:
9:00 AM-5:00 PM Short Course 1: Bayesian Statistics and Bayesian Models for Practical Dose Finding and Dose Optimization Oncology Clinical Trials TBD
Instructors:
12:30-1:30 PM Lunch for all courses TBD
1:30-5:00 PM Short Course 3: Causal generalist medical AI: turning scattered evidence into causal knowledge and clinical action TBD
Instructor:

Conference Program Day 2 (Sun Nov 22, 2026)

Time Session Location People
8:30-9:00 AM Registration and Breakfast TBD
9:00-9:10 AM Opening Remark TBD
9:10-10:00 AM Keynote Session 1: Oncology Keynote TBD
Speaker:
Moderator:
  • Shivaani Kummar, MD, OHSU
10:00-10:20 AM Break (Poster Session 1) TBD
10:20-11:40 AM Invited Session 1: Advancing in Platform and Basket Trials in Oncology TBD
Moderator:
Speakers:
  • Kohei Uemura, University of Tokyo
  • J. Jack Lee, PhD, The University of Texas MD Anderson Cancer Center
  • Toshiki Masuishi, MD, Aichi Cancer Center
  • Hiroya Taniguchi, MD, Aichi Cancer Center
10:20-11:40 AM Invited Session 2: Emerging Trends in Oncology Drug Development - Regulatory, Statistical, and Clinical Perspectives TBD
Moderator:
  • Chin-Fu Hsiao, PhD, NHRI
Speakers:
  • Hui-Jen Tsai, MD, PhD, NHRI
  • Tzy-Chy Lin, MD, PhD, Taiwan CDE
  • Shunsuke Shiota, MMS, PMDA
  • Kenichi Nakamura, MD, PhD, NCC Japan
11:40 AM-12:40 PM Lunch (Poster Session 1) TBD
12:40-1:30 PM Keynote Session 2: Clinical Trial Keynote TBD
Speaker:
Moderator:
1:30-1:50 PM Break (Poster Session 1) TBD
1:50-3:20 PM Plenary Session 1: Building Better Evidence for Pediatric Oncology and Rare Diseases: Rethinking Trials, Decisions, and Global Drug Development TBD
Organizers:
Moderator:
  • Haitao Pan, PhD, St. Jude
Panelists:
  • Elizabeth Fox, MD, St. Jude
  • Ryuma Tanaka, MD, Nationwide Children’s Hospital / The Ohio State University
  • Noriko Mitsuiki, MD, PhD, Institute of Science Tokyo
  • Kentaro Takeda, PhD, Astellas
  • Vicky Qian Wu, PhD, Fred Hutch
  • Luyan Dai, PhD, G-Plume Group
3:20-3:40 PM Break (Poster Session 1) TBD
3:40-5:00 PM Invited Session 3: Dose Optimization TBD
Moderator:
  • Tony Jiang, PhD, Astellas
Speakers:
  • Yeonhee Park, PhD, Sungkyunkwan University
  • Masahiro Kojima, PhD, Chuo University
  • Kanji Komatsu, Astellas
  • Marc Buyse, ScD, University of Hasselt
3:40-5:00 PM Invited Session 4: Data Science in Oncology: From Data to Clinical Impact TBD
Moderator:
  • Chao Agnes Hsiung, PhD, NHRI
Speakers:
5:00-5:45 PM Break (Poster Session 1) TBD
5:45-8:45 PM Banquet SALON AGORA, 9th Floor
Banquet speaker:

Conference Program Day 3 (Mon Nov 23, 2026)

Time Session Location People
8:30-9:00 AM Registration and Breakfast TBD
9:00-9:50 AM Keynote Session 3: Bioinformatics/AI Keynote TBD
Speaker:
Moderator:
  • Shannon McWeeney, PhD, OHSU
9:50-10:10 AM Break (Poster Session 2) TBD
10:10-11:30 AM Invited Session 5: Treatment Switching in Oncology Trials: Methods, Applications, and Regulatory Perspectives TBD
Moderator:
Panelists:
10:10-11:30 AM Invited Session 6: From Data to Evidence - Statistical Learning and AI Methods for Oncology Trials TBD
Moderator:
Speakers:
  • Ruitao Lin, PhD, MD Anderson Cancer Center
  • Shouhao Zhou, PhD, Penn State
  • Arsela Prelaj, MD, ESMO / IRCCS INT Milan
  • Wei Wei, PhD, Yale
11:30 AM-12:30 PM Lunch (Poster Session 2) TBD
12:30-1:20 PM Keynote Session 4: Regulatory Keynote TBD
Speaker:
Moderator:
  • Satoshi Hattori, PhD, Osaka University
1:20-1:40 PM Break (Poster Session 2) TBD
1:40-3:00 PM Invited Session 7: Development of AI-powered prognostic and predictive biomarkers to guide treatment TBD
Moderator:
  • Shivaani Kummar, MD, OHSU
Speakers:
1:40-3:00 PM Invited Session 8: Rapid talks TBD
Moderator:
  • Byung Park, PhD, OHSU
Speakers:
3:00-3:20 PM Break (Poster Session 2) TBD
3:20-4:50 PM Plenary Session 2: Panel discussion on new regulatory guidelines on RWD, rare disease, biomarker, and Bayesian statistical methods TBD
Moderator:
Panelists:
4:50-5:00 PM Closing Remarks TBD

Short Course Day 4 (Tue Nov 24, 2026)

Time Session Location People
8:30-9:00 AM Registration / Breakfast TBD
9:00 AM-12:30 PM Short Course 5: Biomarker-Driven Trials for Precision Oncology TBD
Instructors:
9:00 AM-5:00 PM Short Course 4: Beyond the Hazard Ratio: RMST and Other Measures for Survival Analysis TBD
Instructors:
12:30-1:00 PM Lunch for all courses TBD
1:00-4:00 PM Short Course 6: Statistical Methods Addressing Treatment Switching in Oncology Trials TBD
Instructors: